4bc6: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
[[Category: Canning, P]] | [[Category: Canning, P]] | ||
[[Category: Chaikuad, A]] | [[Category: Chaikuad, A]] | ||
[[Category: Delft, F | [[Category: Delft, F von]] | ||
[[Category: Edwards, A]] | [[Category: Edwards, A]] | ||
[[Category: Elkins, J]] | [[Category: Elkins, J]] |
Revision as of 22:46, 24 January 2018
Crystal structure of human serine threonine kinase-10 bound to novel Bosutinib Isoform 1, previously thought to be BosutinibCrystal structure of human serine threonine kinase-10 bound to novel Bosutinib Isoform 1, previously thought to be Bosutinib
Structural highlights
Disease[STK10_HUMAN] The disease may be caused by mutations affecting the gene represented in this entry.[1] Function[STK10_HUMAN] Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo.[2] [3] [4] References
|
|